Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review
Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands.
Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands; Amsterdam UMC, Department of General Practice, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Amsterdam Public Health Research Institute, Methodology, Amsterdam, Netherlands.
Amsterdam UMC, Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 66, nr 8, s. 1357-1377Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

Patient-reported outcomes (PROs) are valuable for shared decision making and research. Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs, such as health-related quality of life (HRQL). Although core outcome sets for trials and clinical practice have been developed separately, they, as well as other initiatives, recommend different PROs and PROMs. In research and clinical practice, different PROMs are used (some generic, some disease-specific), which measure many different things. This is a threat to the validity of research and clinical findings in the field of diabetes. In this narrative review, we aim to provide recommendations for the selection of relevant PROs and psychometrically sound PROMs for people with diabetes for use in clinical practice and research. Based on a general conceptual framework of PROs, we suggest that relevant PROs to measure in people with diabetes are: disease-specific symptoms (e.g. worries about hypoglycaemia and diabetes distress), general symptoms (e.g. fatigue and depression), functional status, general health perceptions and overall quality of life. Generic PROMs such as the 36-Item Short Form Health Survey (SF-36), WHO Disability Assessment Schedule (WHODAS 2.0), or Patient-Reported Outcomes Measurement Information System (PROMIS) measures could be considered to measure commonly relevant PROs, supplemented with disease-specific PROMs where needed. However, none of the existing diabetes-specific PROM scales has been sufficiently validated, although the Diabetes Symptom Self-Care Inventory (DSSCI) for measuring diabetes-specific symptoms and the Diabetes Distress Scale (DDS) and Problem Areas in Diabetes (PAID) for measuring distress showed sufficient content validity. Standardisation and use of relevant PROs and psychometrically sound PROMs can help inform people with diabetes about the expected course of disease and treatment, for shared decision making, to monitor outcomes and to improve healthcare. We recommend further validation studies of diabetes-specific PROMs that have sufficient content validity for measuring disease-specific symptoms and consider generic item banks developed based on item response theory for measuring commonly relevant PROs.

Ort, förlag, år, upplaga, sidor
Springer, 2023. Vol. 66, nr 8, s. 1357-1377
Nyckelord [en]
Diabetes, Patient-reported outcome, Patient-reported outcome measure, Review, Standardisation
Nationell ämneskategori
Endokrinologi och diabetes
Identifikatorer
URN: urn:nbn:se:umu:diva-209163DOI: 10.1007/s00125-023-05926-3ISI: 000994500100001PubMedID: 37222772Scopus ID: 2-s2.0-85160270888OAI: oai:DiVA.org:umu-209163DiVA, id: diva2:1765686
Tillgänglig från: 2023-06-12 Skapad: 2023-06-12 Senast uppdaterad: 2023-12-05Bibliografiskt granskad

Open Access i DiVA

fulltext(828 kB)144 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 828 kBChecksumma SHA-512
90242b226f4e122401d854d2c47fe27b590a9a51f802ca128774798e46301a12c53b784bcdd8223847f77d966880d72f9d2e6e95a4c1ea54c30b14e3b83a372e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Rolandsson, Olaf

Sök vidare i DiVA

Av författaren/redaktören
Rolandsson, Olaf
Av organisationen
Allmänmedicin
I samma tidskrift
Diabetologia
Endokrinologi och diabetes

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 249 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 350 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf